Prolonged remissions in acute myelocytic leukemia in adults.
D000293:Adolescent; D000324:Adrenocorticotropic Hormone / Q000627:therapeutic use; D000328:Adult; D000367:Age Factors; D000477:Alkylating Agents / Q000627:therapeutic use*; D003078:Colchicine / Q000627:therapeutic use; D005260:Female; D005500:Follow-Up Studies; D005938:Glucocorticoids / Q000627:therapeutic use*; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy*; D008297:Male; D015122:Mercaptopurine / Q000627:therapeutic use*; D008775:Methylprednisolone / Q000627:therapeutic use; D008875:Middle Aged; D011241:Prednisone / Q000627:therapeutic use; D011379:Prognosis; D013148:Spironolactone / Q000627:therapeutic use; D014222:Triamcinolone Acetonide / Q000627:therapeutic use; D014227:Triazines / Q000627:therapeutic use; D014498:Uracil / Q000031:analogs & derivatives / Q000627:therapeutic use
D000477:Alkylating Agents; D005938:Glucocorticoids; D014227:Triazines; D013148:Spironolactone; D014498:Uracil; D000324:Adrenocorticotropic Hormone; D015122:Mercaptopurine; D014222:Triamcinolone Acetonide; D003078:Colchicine; D011241:Prednisone; D008775:Methylprednisolone